US FDA approves new blood cancer treatment from Pfizer
The company plans to launch the drug, Daurismo, in the US by early December with a monthly list price of $16,925
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indoco’s Goa Plant II & III clears US FDA inspection
This positive development will now pave the way for approval of our pending ANDAs with consequent boost to revenues from the US…
Environmental exposures early in life modify immune responses
Studies have shown that immunological development and maturation starts already during pregnancy and in early childhood
Glenmark receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL
The drug is the generic version of Mepron 1 Oral Suspension, 750 mg/5 mL, of GlaxoSmithKline
Piramal Pharma Solutions unveils cGMP kilo lab suite for API
The suite in Chennai will formally open on December 1, 2018
US court rules in favour of DRL on generic Suboxone
A patent infringement case was filed by pharma giant Indivior on selling generic version of Suboxone
Dr Reddy's Laboratories…
Lupin launches generic of Xenazine in US
The company has received approval from US FDA earlier this year
Handful of pharma companies developing urgently needed new medicines for poor: The Access to…
The analysis indicates that the majority of the priority R&D projects are being carried out with public sector research…
ICT to organise 2nd Biosimilar Workshop 2018 in Mumbai
The event will be conducted in collaboration with US Pharmacopeia, BIRAC, C-CAMP and ABLE
Institute of Chemical Technology (ICT)…
Glenmark gets US FDA nod for generic acne treatment gel
The approval granted is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma